TAMPA, Fla., Dec. 31, 2004 (PRIMEZONE) -- Rx Processing Corporation announces stock buy back plan. At 4:30 pm December 30th a special session of the Board Of Directors was held to discuss and authorize the Common Stock Buy Back for 2005.
Peter Fiorillo, Chairman / CEO of Rx Processing Corp announces, "The Common Stock Buy Back for 2005 authorizes the CEO to purchase from the public markets up to 3,000,000 Shares of Rx Processing Corps Common Stock in 2005 at any reasonable market price. All shares of common stock purchased by Rx Processing Corp will be held under restriction, not to be resold for a term of 2 years, in the company's treasury."
Americans who have no prescription insurance coverage have turned to Rx Processing, which offers FDA approved American generic and low-cost Canadian brand name drugs. Rx Processing's state-of-the-art technology finds the best prescription drug prices for these customers by sending their prescriptions to licensed pharmacies to be filled. Rx Processing provides access to prescription drugs for the 40 million Americans without prescription drug coverage that spend billions of dollars on their prescription drugs per year.
Rx Processing is rapidly becoming a market leader in providing prescription drugs to U.S. Citizens, corporations, unions, and prescription benefit plans through licensed pharmacies in the United States and Canada. The Company provides access to over 1,500 approved name brand and generic medications ready for distribution in the U.S. market through its Company owned and operated storefront locations and over 130 affiliated storefronts. By utilizing Rx Processing, U.S. citizens can save up to 84% on their daily prescriptions. Ordering these reduced cost medications are available at the Company's affiliate retail storefronts and information about the company can be found at www.rxprocessingcorp.com
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.